Chronic dry eye is a condition where your tears can’t adequately protect and lubricate the surface of your eyes, leading to persistent irritation, stinging, and blurred vision. It affects roughly 35% of people worldwide and becomes a self-reinforcing cycle: the initial dryness triggers inflammation, which damages the cells responsible for producing healthy tears, which makes the dryness worse. Understanding what’s actually happening in your eyes helps explain why over-the-counter drops sometimes aren’t enough.
How Dry Eye Becomes Chronic
Your tear film isn’t just water. It’s a layered structure with an oily outer layer that prevents evaporation, a watery middle layer that hydrates, and a mucus layer that helps tears stick to the eye’s surface. When any of these layers breaks down, the remaining tears become saltier than normal. That increased saltiness directly damages cells on the surface of your eye and kicks off an inflammatory response.
Here’s what makes dry eye chronic rather than temporary: inflammation is both a cause and a consequence. Once your eye surface becomes inflamed, immune cells flood into the tissue around your eyes and tear glands. These immune cells release signaling molecules that recruit even more immune cells, expanding the scope of inflammation. Meanwhile, proteins that normally protect your eye surface, like lactoferrin, decrease. The inflammation damages your tear glands further, they produce fewer or lower-quality tears, and the cycle accelerates. This is why dry eye that starts as mild discomfort can gradually worsen over months or years without treatment.
Two Types With Different Patterns
Dry eye falls into two main categories, though many people have a mix of both.
Evaporative dry eye is the more common form. It’s driven by problems with the tiny oil-producing glands lining your eyelids, called meibomian glands. When these glands become blocked or dysfunctional, the oily outer layer of your tear film is too thin, and your tears evaporate too quickly. If your eyes feel worse as the day goes on, especially after reading or screen time, evaporative dry eye is the likely culprit.
Aqueous deficient dry eye means your tear glands simply aren’t producing enough of the watery component. This type is more closely linked to autoimmune conditions like Sjögren’s syndrome, where the immune system gradually destroys the tear glands themselves. If your eyes feel worst when you first wake up, this pattern points toward aqueous deficiency.
Who Gets It and Why
A large meta-analysis covering over 15 million people found a global prevalence of 34.6%, with women affected more often than men (39% vs. 31%). In North America, the rate is closer to 21%. People over 40 have a somewhat higher risk, but dry eye is increasingly common in younger adults due to screen use and contact lens wear.
Several everyday medications can cause or worsen dry eye. Antihistamines reduce tear production as a side effect of blocking allergy signals. Antidepressants, particularly tricyclic types, interfere with the nerve signals that tell your eyes to produce tears. SSRIs can also contribute, though through a different mechanism. Beta-blockers used for blood pressure lower a key protein in your tears and reduce fluid production. Isotretinoin, prescribed for severe acne, shrinks the oil glands in your eyelids. Even birth control pills and hormone replacement therapy play a role: women taking estrogen alone are significantly more likely to develop dry eye than those taking estrogen combined with progesterone. If you’re on any of these medications and noticing eye dryness, that connection is worth exploring with your prescriber.
What Testing Looks Like
Diagnosing chronic dry eye typically involves two straightforward tests. In the Schirmer test, a small paper strip is placed on the inside of your lower eyelid for five minutes. The strip absorbs your tears, and less than 10 millimeters of wetting suggests insufficient tear production. It’s mildly uncomfortable but not painful.
The tear break-up time test measures how stable your tear film is. Your eye doctor places a drop of fluorescein dye in your eye, then watches under a blue light while you hold your eyes open without blinking. They’re timing how many seconds it takes for dry spots to appear on your cornea. A stable tear film lasts at least 8 to 10 seconds. Shorter than that points to tear film instability, the hallmark of chronic dry eye.
Treatment Options by Severity
Mild dry eye often responds to over-the-counter artificial tears used consistently throughout the day. Preservative-free formulations are gentler for frequent use. But when the underlying inflammation has taken hold, lubricating drops alone just mask symptoms without breaking the cycle.
Prescription eye drops target the inflammation driving chronic dry eye. The most established option uses cyclosporine, an immune-suppressing compound that calms the overactive immune cells on your eye surface, reduces inflammatory signaling, and over time actually helps restore your natural tear production. These drops are used twice daily but take several weeks to reach full effect, which can be frustrating for people expecting immediate relief.
A newer option approved by the FDA is perfluorohexyloctane (sold as Miebo), which works differently from anti-inflammatory drops. It forms a thin barrier over your tear film that physically prevents evaporation of the watery layer underneath. In two clinical trials, patients using it four times daily for eight weeks showed significantly improved corneal surface smoothness and reported meaningfully lower dryness scores compared to saline drops. This approach is particularly relevant for the evaporative form of dry eye.
In-Office Procedures
When drops aren’t enough, two common procedures address different aspects of the problem. Punctal plugs are tiny devices inserted into your tear ducts (the small openings at the inner corners of your eyelids) to slow tear drainage and keep more moisture on your eye. The logic is simple, but there’s a significant limitation: if your underlying problem is blocked oil glands, you’re retaining tears that are already poor quality. Plugs can also trap inflammatory molecules on the eye surface, potentially worsening symptoms in people with eyelid inflammation. They can fall out, cause irritation, and need periodic replacement.
Intense pulsed light (IPL) therapy takes a more corrective approach for people with meibomian gland dysfunction. Controlled light pulses are applied to the skin below your eyes, delivering heat that softens and liquefies blocked gland secretions, reduces inflammation in the surrounding tissue, and eliminates microscopic mites that can colonize eyelash follicles. The goal is restoring your glands’ ability to produce the oil layer your tear film needs, which over time can reduce dependence on artificial tears. Multiple sessions are typically required.
What Happens Without Treatment
Chronic dry eye isn’t just uncomfortable. Your tears are a frontline defense against infection, and when that barrier thins, bacteria and other pathogens have easier access to the cornea. Untreated severe dry eye can progress to corneal abrasions, where the surface of your eye literally breaks down. In the worst cases, corneal ulcers develop, which are open sores on the eye that can scar permanently and lead to vision loss. These complications are uncommon with appropriate management, but they underscore why persistent dry eye symptoms deserve more than occasional artificial tears.